Novasep invests €6M to Further Expand API Production Capacity at its Chasse-sur-Rhône Site

Novasep, a supplier of services and technologies for the life sciences industry, has announced a €6 million investment on its Chasse-sur-Rhône site, France (38). This investment will increase and modernize its manufacturing capabilities to support new generation Active Pharmaceutical Ingredients (APIs), in areas such as oncology, central nervous system (CNS) and infectious diseases.

Continuous, or flow chemistry, is becoming increasingly important in API manufacturing, offering a number of advantages over traditional batch chemistry such as improved productivity, reduced energy and solvent consumption, better reaction control, increased process safety and reduced exposure for personnel.

Flow chemistry is one of Novasep's main current areas of innovation, with the establishment of a research platform in flow chemistry at its Chasse-sur-Rhône site back in 2013 to develop methodologies for efficient process development under continuous flow conditions, using both internal chemical and engineering expertise. This latest investment strengthens these capacities with the installation of a cGMP flow reactor to support the needs of pharmaceutical innovators for clinical supply and launch.

In parallel, Novasep continues to reinforce its capabilities on the site for low to medium volume APIs, in response to increased customer demand, [through the debottlenecking of drying and purification capacities, and the addition of a new clean room]. These investments will enable Novasep to accommodate customers’ growing needs for outsourced API manufacturing services, increasing flexibility, reinforcing state-of-the art technologies, and strengthening its competitiveness.

This investment project has been selected and supported by the French government as part of the ‘France Relance’ recovery plan. The program rewards innovative and promising industrial investments in France, with the aim of reinforcing production capabilities of APIs for essential therapies, increasing economic growth and boosting employment.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion